Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
734.97
-20.94 (-2.77%)
Official Closing Price
Updated: 7:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
77
78
Next >
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
Today 14:49 EDT
These stocks have rock-solid businesses and they have impressive track records for paying dividends.
Via
The Motley Fool
3 No-Brainer Stocks to Buy in May
Today 6:55 EDT
These great stocks are great picks for investors as spring winds down.
Via
The Motley Fool
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
May 04, 2024
Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
Via
The Motley Fool
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
May 04, 2024
The anti-obesity medication stock is way up, and there could be more fuel in the tank.
Via
The Motley Fool
Why Amgen Stock Zoomed Nearly 12% Higher Today
May 03, 2024
The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.
Via
The Motley Fool
3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030
May 03, 2024
These under-the-radar stocks have the potential to reach a $1 trillion valuation by 2030 as they gain momentum in their respective industries.
Via
InvestorPlace
Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry
May 03, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
May 02, 2024
Via
Benzinga
Here's Why Eli Lilly Stock Remains a Screaming Buy
May 02, 2024
The biggest healthcare company in the world could grow much larger over the next decade.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 03, 2024
Via
Benzinga
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
May 03, 2024
The Nasdaq regained its 50-day line Friday. The other indexes hit resistance.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up
May 03, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
May 01, 2024
Via
Benzinga
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
May 02, 2024
The company seems to be going from strength to strength lately.
Via
The Motley Fool
Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 02, 2024
Reduced prices on Wegovy and Mounjaro at British pharmacies amid growing competition. Simple Online Pharmacy slashes Mounjaro starter doses to £149 from £179, catering to high demand.
Via
Benzinga
3 Stocks Gunning for Trillion-Dollar Status: The Players to Own Now
May 02, 2024
These three stocks closing in on trillion-dollar valuations are ready to stand shoulder-to-shoulder with other industry giants.
Via
InvestorPlace
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
May 02, 2024
The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly.
Via
Benzinga
Q1 Earnings Seasons Picks & Pans: The 4 Biggest Stock Winners (and 3 Losers)
May 01, 2024
Investors should take note of this earnings season winners and losers to see how stocks they own are doing now Q1 results have been released.
Via
InvestorPlace
Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots'
May 01, 2024
Eli Lilly's first-quarter report shows a revenue surge of 26%, beating EPS expectations. Analysts maintain a bullish outlook.
Via
Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 01, 2024
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest...
Via
Talk Markets
Topics
ETFs
Profit from the Panic: 3 Stocks to Pounce on When They Become Steals
May 01, 2024
We love it when our favorite clothes go on sale, so when the market offers us a deal, these are the stocks to buy on dips.
Via
InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Consumer Stocks.
May 01, 2024
While some retail companies are still thriving, investors would be smart to steer clear of these consumer stocks to avoid.
Via
InvestorPlace
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
May 01, 2024
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.
Via
InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
May 01, 2024
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.
Via
InvestorPlace
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
May 01, 2024
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for...
Via
Benzinga
Exposures
COVID-19
Nearly 50% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 4 Stocks
May 01, 2024
The billionaire's family fund is surprisingly concentrated.
Via
The Motley Fool
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.
May 01, 2024
We also look at the "treasure hunt" economy.
Via
The Motley Fool
These 3 Companies Recently Lifted Guidance
May 01, 2024
Several companies have raised their outlooks, with shares moving higher following the announcements. For those interested in recent bullish activity, let’s take a closer look at each.
Via
Talk Markets
Americans Swap $5 Burgers For $1,000 Weight Loss Drugs — Is Soda Getting Left Behind Too?
April 30, 2024
Weight-loss drugs may be impacting fast-food sales, as Eli Lilly beats estimates and raises revenue guidance while McDonald's and Coca-Cola report underwhelming quarters.
Via
Benzinga
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs
April 30, 2024
Eli Lilly boosts production for obesity and diabetes drugs, reports mixed Q1 results. Expectations for supply growth in 2024 outlined. Insights into payor access and reimbursement strategies...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
77
78
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.